Impact of glucagon-like peptide-1 receptor agonists with guideline-directed medical therapy in patients with heart failure with reduced ejection fraction and type 2 diabetes

Heart FailureTherapy and Intervention

Clinical Application of Guideline-Directed Medical Therapy in TAVR Patients With Heart Failure and Reduced Ejection Fraction

JACC Cardiovasc Interv

Kobari Y, Maznyczka A, Khokhar AA, Sørensen LM, Lulic D, Bieliauskas G, Raja AA, Ersbøll MK, Rossing K, Gustafsson F, Køber L, Prendergast B, Fosbøl E, De Backer O

doi: 10.1016/j.jcin.2025.10.050

Heart Failure

Impact of contemporary guideline-directed medical therapy on secondary mitral and tricuspid regurgitation in heart failure with reduced ejection fraction

Eur J Heart Fail

Naser JA, Rahme SJ, Castrichini M, Ibrahim H, Scott CG, Kennedy AM, Eleid MF, Nkomo VT, Foley DA, McKie PM, Borlaug BA, Pislaru SV, Lin G

doi: 10.1093/ejhf/xuag047

Heart Failure

Real-life implementation of guideline-recommended medical therapy in heart failure with reduced ejection fraction: Effects on prognosis and left ventricular ejection fraction. Primary results of TITRATE-HF

Eur J Heart Fail

Malgie J, Wilde MI, Koudstaal S, Denham R, da Fonseca CA, Swart HP, van Ofwegen CEE, Yilmaz A, Pisters R, Linssen GCM, Faber N, van Heerebeek L, van de Swaluw JEC, de Boer RA, Brunner-La Rocca HP, Brugts JJ

doi: 10.1002/ejhf.70006

Heart Failure

One-Year Outcomes in Patients Hospitalized for Heart Failure With Reduced Ejection Fraction Prescribed Quadruple Medical Therapy at Discharge

JAMA Cardiol

Greene SJ, Xu H, Chiswell K, Felker GM, Lewsey SC, Divanji PH, Goertz HP, Heitner SB, Shreay S, Pandey A, Yancy CW, Butler J, Fonarow GC

doi: 10.1001/jamacardio.2025.5339

Heart Failure

Survival benefit of guideline-directed medical therapy in older patients with heart failure: a systematic review and meta-analysis

Heart

Tan E, Meei-Wah C, Teo YH, Tan LF, Ho VWT, Lin W, Yeo TC, Wong RCC, Chai P, Kong W, Sia CH

doi: 10.1136/heartjnl-2025-326305

Heart Failure

Prognostic impact of rheumatic diseases in patients with heart failure with mildly reduced ejection fraction

Clin Res Cardiol

Goertz M, Schupp T, Dudda J, Weidner K, Lau F, Schmitt A, Abel N, Abumayyaleh M, Steffen HJ, Langer HF, Duerschmied D, Akin I, Behnes M

doi: 10.1007/s00392-025-02740-2

Heart Failure

Contemporary Guideline-Directed Medical Therapy for Heart Failure in the United States: The EMPACE Study

J Am Heart Assoc

Greene SJ, Adam A, Schmedt N, Carlsen C, Brand M, Davies E, Jouaville Abrouk LS, Prochaska JH, Tran P, Alhamdow A

doi: 10.1161/JAHA.125.044785

Heart Failure

Time to Quadruple Therapy After Initial Diagnosis of Heart Failure With Reduced Ejection Fraction

JAMA Cardiol

Jacobs JA, Greene T, Vanneman ME, Kean J, Carter SJ, Shah KS, Pandey A, Derington CG, Zheutlin AR, Fang J, Stehlik J, Fonarow GC, Bress AP

doi: 10.1001/jamacardio.2026.0375

Heart Failure

Effectiveness of an Intervention to Improve Guideline-Directed Medications for Patients With Acute Heart Failure: A Randomized Clinical Trial

J Am Heart Assoc

Son JW, Cho DH, Kim SE, Choi J, Choi DJ, Cho HJ, Lee CJ, Choi JO, Lee SE, Kim EJ, Chung WJ, Youn JC, Bae DH, Park JH, Kim KH, Kim IC, Choi JH, Lee S, Kim H, Yoo BS

doi: 10.1161/JAHA.125.044747

Related content

Clinical Application of Guideline-Directed Medical Therapy in TAVR Patients With Heart Failure and Reduced Ejection Fraction

Impact of contemporary guideline-directed medical therapy on secondary mitral and tricuspid regurgitation in heart failure with reduced ejection fraction

Real-life implementation of guideline-recommended medical therapy in heart failure with reduced ejection fraction: Effects on prognosis and left ventricular ejection fraction. Primary results of TITRATE-HF

One-Year Outcomes in Patients Hospitalized for Heart Failure With Reduced Ejection Fraction Prescribed Quadruple Medical Therapy at Discharge

Survival benefit of guideline-directed medical therapy in older patients with heart failure: a systematic review and meta-analysis

Prognostic impact of rheumatic diseases in patients with heart failure with mildly reduced ejection fraction

Contemporary Guideline-Directed Medical Therapy for Heart Failure in the United States: The EMPACE Study

Time to Quadruple Therapy After Initial Diagnosis of Heart Failure With Reduced Ejection Fraction

Effectiveness of an Intervention to Improve Guideline-Directed Medications for Patients With Acute Heart Failure: A Randomized Clinical Trial